This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ONLINE REGISTRATION CLOSES IN:

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

David Younger, Ph.D.
Co-Founder & CEO at A-Alpha Bio

Profile

David Younger is the Co-Founder and CEO of A-Alpha Bio, a Seattle-based biotechnology company using synthetic biology and next generation sequencing to measure millions of protein-protein interactions and improve antibody discovery and optimization. David invented A-Alpha Bio’s AlphaSeq platform with Scientific Advisors David Baker and Eric Klavins at the University of Washington, where he earned his PhD in Bioengineering. David’s technical expertise spans synthetic biology, protein engineering, and Next Generation Sequencing assay development.

Agenda Sessions

  • Massively Multiplexed Epitope Mapping and Specificity/Cross-reactivity Characterization with Yeast Mating

    8:15am